Brian J. Backskai, Ph.D.
Alzheimer's Disease Research Unit
Massachusetts General Hospital
Roberta Diaz Brinton, Ph.D.
R. Pete Vanderveen Chair in Therapeutic Discovery and Development Professor of Pharmacology and Pharmaceutical Sciences, and Biomedical Engineering Norris Foundation Laboratory for Neuroscience Research Director, USC STAR Science Education Program
University of Washington School of Medicine
University of Southern California School of Pharmacy
Los Angeles, California
Michela Gallagher, Ph.D.
Vice Provost for Academic Affairs
Krieger-Eisenhower Professor of Psychology and Neuroscience
Department of Psychological and Brain Sciences
Johns Hopkins University
Gunnar K. Gouras, M.D.
Professor of Neurology and Neuroscience
Director, Laboratory of Alzheimer's Neurobiology
Weill Cornell Medical College
New York, New York
Martin Inglesson, M.D., Ph.D.
Department of Public Health
Donald C. Lo, Ph.D.
Director, Center for Drug Discovery
Department of Neurobiology
Duke University Medical Center
Durham, North Carolina
Eric M. Reiman, M.D.
Executive Director, Banner Alzheimer's Institute, Chief Scientific Officer, Banner Health Research
Clinical Director, Neurogenomics Division, Translational Genomics Research Institute
Professor and Associate Head of Phsychiatry, University of Arizona
Director, Arizona Alzheimer's Consortium, Phoenix, Arizona
Mark S. Shearman, Ph.D.
Vice President, Head of Neuropharmacology and Biology
Neurodegenerative Disease Research
EMD Serono Research Insitute
Akihiko Takashima, Ph.D.
Head, Laboratory for Alzheimer's Disease
Executive Vice President, Research, and Chief Scientific Officer
South San Francisco, California
Michael Wolfe, M.D.
Center for Neurologic Diseases
Harvard Medical School